Efficacy of Combining Ultrasound-Guided Needle Release of Transverse Carpal Ligament and Median Nerve Dextrose Water Hydrodissection for Carpal Tunnel Syndrome
Recruiting
N/A
Interventional Study
Carpal Tunnel Syndrome
Dextrose
Carpal Tunnel Release
Ultrasound
Nerve Hydrodissection Therapy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 20 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 102 (estimated)
- Sponsor
- Shin Kong Wu Ho-Su Memorial Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Carpal tunnel syndrome (CTS) is a common musculoskeletal disorder, which is caused by compression of the median nerve as it travels through the wrist. There are several treatments for CTS, including conservative and surgical options. Though local corticosteroid injection has been considered more effective than physical therapy for treatment of CTS and has significant short-term benefits, long term…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* age between 20 to 80 years old
* diagnosed with CTS on the basis of clinical condition and an electrophysiological analysis
* the NRS of pain or paresthesia≧3
* with symptoms lasting for a minimum of 3 months.
Exclusion Criteria:
* history of polyneuropathy, thoracic outlet …
Contacts